Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 10/20 | 0.47 |
| ▸ | HTR1A | P08908 | 9/20 | 0.47 |
| ▸ | DRD2 | P14416 | 9/20 | 0.47 |
| ▸ | HTR2A | P28223 | 9/20 | 0.47 |
| ▸ | HTR6 | P50406 | 9/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3809514 | 1.00 | HTR7 (0.47) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL21449078 | 0.98 | HTR7 (0.46) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL15294299 | 0.98 | HTR7 (0.45) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL4163258 | 0.96 | TLR8 (0.46) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL14128217 | 0.91 | HRH3 (0.47) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL10916174 | 0.91 | HTR7 (0.51) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL1410625 | 0.91 | HTR7 (0.51) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL21325619 | 0.91 | HTR7 (0.51) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL10454909 | 0.91 | HTR7 (0.51) | HTR7HTR1ADRD2HTR2AHTR6 | |
| SCHEMBL10953749 | 0.91 | HTR7 (0.51) | HTR7HTR1ADRD2HTR2AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113056199-A | Trisubstituted biguanide compounds and uses thereof | 陈煌兴 | 2021-06-29 | — | — | CN | claimed |
| CN-110121548-A | Branched polymeric biguanide compound and application thereof | 陈煌兴 | 2019-08-13 | — | — | CN | claimed |
| US-12404287-B2 | Chemical compound, surface treating agent, surface treating method, and production method for metal-resin composite | MEC COMPANY LTD. (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-118420553-B | Compound, surface treatment agent, surface treatment method, and method for producing metal-resin composite | MEC股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20240270763-A1 | CHEMICAL COMPOUND, SURFACE TREATING AGENT, SURFACE TREATING METHOD, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | MEC COMPANY LTD. (JP) | 2024-08-15 | — | — | US | disclosed |
| EP-4410798-A1 | CHEMICAL COMPOUND, SURFACE TREATING AGENT, SURFACE TREATING METHOD, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | MEC COMPANY., LTD. (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-118420553-A | Compound, surface treatment agent, surface treatment method, and method for producing metal-resin composite | MEC股份有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-116196898-A | Nanometer ferroferric oxide-cyclodextrin hydrogel adsorbent and preparation method thereof | 郑州师范学院 | 2023-06-02 | — | — | CN | disclosed |
| CN-113056199-A | Trisubstituted biguanide compounds and uses thereof | 陈煌兴 | 2021-06-29 | — | — | CN | disclosed |
| CN-106715535-B | Silane-functionalized compounds and compositions thereof | 瀚森公司 | 2020-01-17 | — | — | CN | disclosed |
| CN-110121548-A | Branched polymeric biguanide compound and application thereof | 陈煌兴 | 2019-08-13 | — | — | CN | disclosed |
| EP-0820539-B1 | MELAMINE RESIN FIBRE AND NATURAL FIBRE MIXTURE | BASF AG (DE) | 1999-09-01 | — | — | EP | disclosed |
| US-5939515-A | Modified melamine-formaldehyde resins | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-17 | — | — | US | disclosed |
| EP-0799260-B1 | PROCESS FOR PREPARING DYED MELAMINE-FORMALDEHYDE CONDENSATION PRODUCTS | BASF AG (DE) | 1999-05-06 | — | — | EP | disclosed |
| US-5888652-A | NATURAL FIBERS CAN BE USED WITHOUT FLAMEPROOFING FINISH; FIRE SAFETY BLANKETS, FIRE PROTECTION SUITS; IMPROVED TENSILE STRENGTH | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-30 | — | — | US | disclosed |
| US-5837013-A | Preparation of colored melamine-formaldehyde condensation products | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-17 | — | — | US | disclosed |
| EP-0523485-B1 | Modified melamine-formaldehyde resins | BASF AG (DE) | 1995-12-13 | — | — | EP | disclosed |
| EP-0179408-B1 | AMIDOALKYL MELAMINES AND AMINOALKYL MELAMINES, AND PROCESS FOR THEIR PREPARATION | BASF Aktiengesellschaft (DE) | 1993-09-08 | — | — | EP | disclosed |
| US-4670558-A | POLYURETHANE INTERMEDIATES | BASF AKTIENGESELLSCHAFT (DE) | 1987-06-02 | — | — | US | disclosed |
| EP-0179408-A2 | Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation | BASF Aktiengesellschaft (DE) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404287-B2 | Chemical compound, surface treating agent, surface treating method, and production method for metal-resin composite | ASH2L, H1-0, MARS1 | HTR7 75/4885HTR1A 90/4885DRD2 885/4885 |
| US-20240270763-A1 | CHEMICAL COMPOUND, SURFACE TREATING AGENT, SURFACE TREATING METHOD, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | ASH2L, H1-0, MARS1 | HTR7 75/4885HTR1A 90/4885DRD2 885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.